MINI-FOCUS: INFLAMMATION IN CARDIAC INJURY The IL-1b Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure

Archive ouverte

Harouki, Najah | Nicol, Lionel | Remy-Jouet, Isabelle | Henry, Jean-Paul | Dumesnil, Anaïs | Lejeune, Annie | Renet, Sylvanie | Golding, Francesca | Djerada, Zoubir | Wecker, Didier | Bolduc, Virginie | Bouly, Muriel | Roussel, Jérôme | Richard, Vincent | Mulder, Paul

Edité par CCSD -

International audience. HIGHLIGHTS Immediate IL-1b antibody gevokizumab administration reduces ischemia/ reperfusion related infarct size. Immediate and late IL-1b antibody gevokizumab administration improves heart failure related left ventricular remodeling. IL-1b antibody gevokizumab improves heart failure related coronary dysfunction. From

Suggestions

Du même auteur

Selective Heart Rate Reduction Improves Metabolic Syndrome–related Left Ventricular Diastolic Dysfunction

Archive ouverte | Merabet, Nassiba | CCSD

International audience. Enhanced heart rate observed in metabolic syndrome (MS) contributes to the deterioration of left ventricular (LV) function via impaired LV filling and relaxation, increased myocardial O2 cons...

Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice

Archive ouverte | Pieronne-Deperrois, Marie | CCSD

International audience. Aims: In post-menopausal women, incidence of heart failure with preserved ejection fraction is higher than in men. Hormonal replacement therapies did not demonstrate benefits. We tested wheth...

Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice

Archive ouverte | Roche, Clothilde | CCSD

International audience. This study addressed the hypothesis that inhibition of the EETs degrading enzyme soluble epoxide hydrolase affords renal protection in the early stage of diabetic nephropathy. The renal effec...

Chargement des enrichissements...